Merck is buying Schering-Plough for $41.1 billion in a deal that gives the companies more firepower to compete in a drug industry facing slumping sales, tough generic competition and intense cost pressures
By Linda Johnson Associated Press, San Jose Mercury News: Business
Mon, 03/09/2009 - 7:56am
Merck is buying Schering-Plough for $41.1 billion in a deal that gives the companies more firepower to compete in a drug industry facing slumping sales, tough generic competition and intense cost pressures